SCHEMBL7612643

SCHEMBL7612643

Cc1nccn1-c1nc(NCCc2ccc3c(c2)OCO3)c2ccsc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCDIN3D Q7Z5W3 1/20 0.43
PDE5A O76074 2/20 0.41
NOS2 P35228 3/20 0.39
NPC1 O15118 1/20 0.39
GALR3 O60755 1/20 0.39
LMNA P02545 1/20 0.39
NR2F2 P24468 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
FLT1 P17948 3/20 0.37
KDR P35968 3/20 0.37
IDO1 P14902 1/20 0.37
NOS1 P29475 1/20 0.37
ACVR1 Q04771 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
FAAH O00519 2/20 0.35
HTR1A P08908 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5130564 0.88 BCDIN3D (0.43) BCDIN3DPDE5ANOS2NPC1GALR3
SCHEMBL5124067 0.86 BCDIN3D (0.42) BCDIN3DPDE5ANOS2LMNASMN1; SMN2
SCHEMBL5123608 0.86 BCDIN3D (0.42) BCDIN3DPDE5ANOS2FLT1KDR
SCHEMBL5122226 0.85 BCDIN3D (0.39) BCDIN3DPDE5ANOS2HTTRAB9A
SCHEMBL5129010 0.84 FLT1 (0.43) BCDIN3DPDE5ANOS2FLT1KDR
SCHEMBL5124186 0.83 SMN1; SMN2 (0.41) BCDIN3DPDE5ANOS2GALR3LMNA
SCHEMBL7618417 0.83 NOS2 (0.52) PDE5ANOS2NOS1
SCHEMBL5124155 0.83 BCDIN3D (0.39) BCDIN3DPDE5ANOS2NPC1RAB9A
SCHEMBL7619052 0.82 BCDIN3D (0.44) BCDIN3DPDE5ANOS2NPC1GALR3
SCHEMBL5122439 0.82 PDE5A (0.39) BCDIN3DPDE5ANOS2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432950-B1 ANTICANCER AGENTS; KILLING CANCER CELLS CELL PATHWAYS 2002-08-13 US disclosed
US-6133271-A Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives CELL PATHWAYS, INC. (US) 2000-10-17 US disclosed